Cantor Fitzgerald Reiterates Overweight on 89bio, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on 89bio (NASDAQ:ETNB) and maintained a $29 price target.
March 04, 2024 | 3:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cantor Fitzgerald analyst Kristen Kluska reiterated an Overweight rating on 89bio and maintained a $29 price target.
The reiteration of an Overweight rating and maintenance of a $29 price target by a reputable analyst suggests a positive outlook on the stock, likely leading to increased investor confidence and potential upward movement in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100